Answers are grounded in this paper and cite their sources.
BACKGROUND: Low serum levels of vitamin D, measured as serum 25-hydroxy-vitamin D (S-25-OHD), have been observed in several cancers. METHODS: Sixty-five adult patients with head and neck cancer, 50 men, median age 61 years (range, 33-77 years), were enrolled in this prospective cohort study. Concentrations of S-25-OHD and plasma calcium (Ca) and phosphate (Pi) were measured before cancer treatment. RESULTS: The mean S-25-OHD was 42.0 (SD 22) nmol/L. Hypovitaminosis D (37.5-50 nmol/L) was found in 20% of the patients and vitamin D deficiency (<37.5 nmol/L) in 45% of the patients. No seasonal variation was seen. Subnormal plasma Ca and Pi levels were found in 11% and 9% of the patients, respectively. CONCLUSION: Subnormal vitamin D levels were found in a significant proportion of the patients. Because vitamin D deficiency may pose these patients to increased risk of therapy-related morbidity, special attention should be paid to correction of this nutritional deficiency.
No takes yet. Share an insight, caveat, or question.
Orell–Kotikangas et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: